Table 2.
Vaccination-related adverse events.
| Vaccine 1 N = 35 |
Vaccine 2 N = 32 |
Vaccine 3 N = 16 |
||
|---|---|---|---|---|
| None | 13 (37%) | 14 (44%) | 5 (31%) | |
| Local pain | Grade 1 | 19 (54%) | 13 (41%) | 7 (23%) |
| Diffuse pain | ||||
| Grade 1 | 2 (6%) | 2 (6%) | 0 | |
| Grade 2 | 0 | 0 | 1 (6%) | |
| Fatigue | ||||
| Grade 1 | 5 (14%) | 5 (16%) | 3 (19%) | |
| Grade 2 | 1 (3%) | 2 (6%) | 2 (13%) | |
| Grade 3 | 1 (3%) | 3 (9%) | 3 (19%) | |
| Fever | Grade 1 | 0 | 1 (3%) | 1 (6%) |
| Vomiting | Grade 2 | 0 | 1 (3%) | 0 |
| Purpura | 0 | 0 | 1 (6%) | |
| Dizziness | 0 | 0 | 1 (6%) |
N = 35 for the first vaccine dose (38 vaccinated, 3 missing data); N = 32 for the second (34 vaccinated, 2 missing data); N = 16 for the third (17 vaccinated, 1 missing data).